Trials / Sponsors / Holostem s.r.l.

Holostem s.r.l.

Industry · 6 registered clinical trials.

Status	Trial	Phase	Started
Terminated	Open-label, Pivotal Clinical Trial to Confirm Efficacy and Safety of Autologous Grafts Containing Stem Cells G Junctional Epidermolysis Bullosa Non-Herlitz Type	Phase 2 / Phase 3	2022-07-15
Terminated	Clinical Trial to Assess the Safety and Efficacy of Investigational Product in Patients Due to Hypospadias Tre Hypospadias	Phase 1 / Phase 2	2021-11-26
Terminated	Clinical Trial to Assess Safety and Efficacy of Autologous Cultured Epidermal Grafts Containing Epidermal Stem Junctional Epidermolysis Bullosa	Phase 1 / Phase 2	2018-03-19
Completed	Follow-up Study After ACLSCT for Restoration of Corneal Epithelium in Patients With LSCD Due to Ocular Burns Limbal Stem Cell Deficiency Due to Ocular Burn	—	2017-12-13
Terminated	Clinical Trial to Assess Safety and Efficacy of Autologous Cultured Epidermal Grafts Containing Epidermal Stem Recessive Dystrophic Epidermolysis Bullosa	Phase 1 / Phase 2	2017-01-30
Completed	Efficacy and Safety of Autologous Cultivated Limbal Stem Cells Transplantation (ACLSCT) for Restoration of Cor Limbal Stem Cells Deficiency	Phase 4	2015-10-01